Semi-specific immuno-absorption and monoclonal antibody therapy in ANCA positive vasculitis: experience in four cases.

Semi-specific immuno-absorption and monoclonal antibody therapy in ANCA positive vasculitis: experience in four cases.

The treatment of renal limited systemic vasculitis usually involves a combination of cytotoxic drugs and steroids. As shown by randomised prospective controlled trial, plasmapheresis may be of additional benefit for the management of patients with renal involvement severe enough to require dialysis...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Elliott, J, Lockwood, C, Hale, G, Waldmann, H
Formaat:	Journal article
Taal:	English
Gepubliceerd in:	1998

Gelijkaardige items

Monoclonal-antibody therapy in systemic vasculitis.
door: Mathieson, P, et al.
Gepubliceerd in: (1990)

MONOCLONAL-ANTIBODY THERAPY IN SYSTEMIC VASCULITIS
door: Mathieson, P, et al.
Gepubliceerd in: (1990)

HUMANIZED MONOCLONAL-ANTIBODY THERAPY FOR SYSTEMIC VASCULITIS
door: Lockwood, C, et al.
Gepubliceerd in: (1993)

Long-term remission of intractable systemic vasculitis with monoclonal antibody therapy.
door: Lockwood, C, et al.
Gepubliceerd in: (1993)

MONOCLONAL-ANTIBODIES IN SYSTEMIC VASCULITIS - LONG-TERM BENEFIT FROM SHORT-TERM THERAPY
door: Isaacs, J, et al.
Gepubliceerd in: (1993)

Personalized Medicine in ANCA-Associated Vasculitis ANCA Specificity as the Guide?
door: Zachary S. Wallace, et al.
Gepubliceerd in: (2019-12-01)

Specificity of monoclonal antibody Campath-1.
door: Hale, G, et al.
Gepubliceerd in: (1988)

ANCA POSITIVE AND ANCA NEGATIVE MICROSCOPIC POLYARTERITIS
door: Adu, D, et al.
Gepubliceerd in: (1994)

HUMANIZED MONOCLONAL-ANTIBODY (MAB) THERAPY FOR WEGENERS GRANULOMATOSIS (WG)
door: Lockwood, C, et al.
Gepubliceerd in: (1995)

Treatment of refractory Wegener's granulomatosis with humanized monoclonal antibodies.
door: Lockwood, C, et al.
Gepubliceerd in: (1996)

Relapse Predictors in Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis
door: Katarzyna Wawrzycka-Adamczyk, et al.
Gepubliceerd in: (2024-08-01)

Relapse in Anti-Neutrophil Cytoplasm Antibody (ANCA)–Associated Vasculitis
door: Alan D. Salama
Gepubliceerd in: (2020-01-01)

Importance of antigen specificity for complement-mediated lysis by monoclonal antibodies.
door: Bindon, C, et al.
Gepubliceerd in: (1988)

Updates in ANCA-associated vasculitis
door: Carolyn Ross, et al.
Gepubliceerd in: (2022-07-01)

Epidemiology of ANCA associated vasculitis
door: Wenche Koldingsnes, et al.
Gepubliceerd in: (2008-01-01)

Positive predictive value of anti-neutrophil cytoplasmic antibody (ANCA) testing for ANCA-associated systemic vasculitis (AASV) in a routine clinical setting
door: McLaren, J, et al.
Gepubliceerd in: (2001)

The Diagnosing Challenge of a Positive ANCA Vasculitis in the Paediatric Age
door: Clara Preto, et al.
Gepubliceerd in: (2017-01-01)

Simultaneous automated screening and confirmatory testing for vasculitis-specific ANCA.
door: Mandy Sowa, et al.
Gepubliceerd in: (2014-01-01)

Pathogenesis and pathology of anti-neutrophil cytoplasmic antibody（ANCA）-associated vasculitis
door: Daisuke Tsukui, et al.
Gepubliceerd in: (2021-01-01)

Placebo-controlled trial of intravenous immunoglobulin in ANCA-associated systemic vasculitis.
door: Jayne, D, et al.
Gepubliceerd in: (1999)

Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity.
door: Jayne, DR, et al.
Gepubliceerd in: (2000)

Therapeutic potential of rat monoclonal antibodies: isotype specificity of antibody-dependent cell-mediated cytotoxicity with human lymphocytes.
door: Hale, G, et al.
Gepubliceerd in: (1985)

Explaining fatigue in ANCA-associated vasculitis.
door: Basu, N, et al.
Gepubliceerd in: (2013)

Damage assessment in ANCA-associated vasculitis.
door: Bhamra, K, et al.
Gepubliceerd in: (2012)

Explaining fatigue in ANCA-associated vasculitis
door: Basu, N, et al.
Gepubliceerd in: (2013)

Diagnosis and management of ANCA associated vasculitis.
door: Berden, A, et al.
Gepubliceerd in: (2012)

Cutaneous manifestations of ANCA-associated vasculitis
door: Chiesafuxench, Z, et al.
Gepubliceerd in: (2016)

Cardiovascular outcomes in ANCA associated vasculitis
door: Mukhtyar, C, et al.
Gepubliceerd in: (2008)

Outcome measures in ANCA-associated vasculitis.
door: Suppiah, R, et al.
Gepubliceerd in: (2010)

The involvement of NETs in ANCA-associated vasculitis
door: Satoka Shiratori-Aso, et al.
Gepubliceerd in: (2023-09-01)

Vasculitis ANCA y esclerosis sistémica
door: Maite Hurtado, et al.
Gepubliceerd in: (2016-11-01)

Complement Inhibition in ANCA-Associated Vasculitis
door: Vladimir Tesar, et al.
Gepubliceerd in: (2022-07-01)

Individualization of the ANCA associated vasculitis treatment
door: Zbigniew Zdrojewski
Gepubliceerd in: (2014-09-01)

Update of Management of ANCA-Associated Vasculitis
door: Hoi San Tang, et al.
Gepubliceerd in: (2021-12-01)

Advantages of rat monoclonal antibodies.
door: Clark, M, et al.
Gepubliceerd in: (1983)

Correction: Simultaneous Automated Screening and Confirmatory Testing for Vasculitis-Specific ANCA.
door: Mandy Sowa, et al.
Gepubliceerd in: (2015-01-01)

Correction: simultaneous automated screening and confirmatory testing for vasculitis-specific ANCA.
door: PLOS ONE Staff
Gepubliceerd in: (2015-01-01)

Anti-plasminogen antibodies in ANCA-associated vasculitis: An optimized anti-plasminogen assay.
door: Arda Göçeroğlu, et al.
Gepubliceerd in: (2018-01-01)

CAMPATH-1 monoclonal antibodies in bone marrow transplantation.
door: Hale, G, et al.
Gepubliceerd in: (1994)

Interest of a Kidney Biopsy to Rule out ANCA-Associated Renal Vasculitis in Glomerulonephritis Patients with a Positive ANCA
door: Florian Garo, et al.
Gepubliceerd in: (2022-04-01)